SWAV Stock Recent News

Shockwave Medical's (SWAV) fourth-quarter results reflect robust revenue growth and gross margin expansion on the back of strong demand and new launches.

Shockwave Medical, Inc. (SWAV) Q4 2023 Earnings Call Transcript

Shockwave Medical (SWAV) came out with quarterly earnings of $1.16 per share, beating the Zacks Consensus Estimate of $0.92 per share. This compares to earnings of $3.71 per share a year ago.

Shockwave Medical is a med-tech company that utilizes Intravascular Lithotripsy technology to treat cardiovascular diseases. The company has a significant market presence and stands to capture a significant share of the expanding global cardiovascular intervention market. Shockwave has impressive financial metrics, positioning it as a standout choice for investors seeking profitability and exponential growth.

Shockwave Medical is a pioneer in intravascular lithotripsy and has recently experienced a reset valuation due to temporary factors. The company has shown strong revenue growth in 2023, but is facing challenges in its current peripheral business and uncertainty in 2024. Despite these obstacles, Shockwave Medical is navigating through the hiccups and working towards continued success.

ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.

Shockwave Medical's (SWAV) third-quarter results reflect robust revenue growth and gross margin expansion on the back of strong demand and new launches.

Shockwave Medical, Inc. (NASDAQ:SWAV ) Q3 2023 Earnings Conference Call November 6, 2023 4:30 PM ET Company Participants Debbie Kaster - Vice President, Investor Relations Doug Godshall - President and Chief Executive Officer Isaac Zacharias - President and Chief Commercial Officer Dan Puckett - Chief Financial Officer Robert Fletcher - Senior Vice President, Marketing & Market Access Conference Call Participants Patrick Wood - Morgan Stanley Travis Steed - Bank of America Adam Maeder - Piper Sandler Larry Biegelsen - Wells Fargo Mike Matson - Needham & Company Imron Zafar - Deutsche Bank Michael Polark - Wolfe Research Mike Kratky - Leerink Danielle Antalffy - UBS Operator Good afternoon and welcome to Shockwave's Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes.

Shockwave Medical (SWAV) came out with quarterly earnings of $0.92 per share, beating the Zacks Consensus Estimate of $0.81 per share. This compares to earnings of $0.92 per share a year ago.

ShockWave Medical (SWAV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.